On December 27, the launch conference of the world's first and national first-class new veterinary drug, Boradeli Dog Albumin Injection, was held in Beijing. This conference brought together many big names in the field of pet medical and surgical field in my country to share their experience in the scientific application of albumin in multiple diseases, and to upgrade the treatment concepts of canine hypovolemia and canine hypoalbuminemia, as well as Bosheng Health’s achievements. Conduct in-depth exchanges on hot topics such as the clinical significance of the batch.

Part.1

Concentrate on making steady progress

In 2018, Bo Laideli obtained a canine serum albumin level The new veterinary drug certificate and the production approval obtained after 5 years are a rare industry persistence for Bo Laideli. National Class I new veterinary drugs are a combination of an enterprise’s soft power in R&D and hard power in production. The world's first initiative reflects the company's contribution to the industry, allowing domestic high-quality biological products to have a place in the international industry. While meeting the needs of the domestic pet medical industry, it also increases its global technological influence.

With the mission of "protecting the health of pets and bringing happiness to humans", Bolaidli always insists on providing safe and effective preventive and therapeutic innovative drugs for clinical pets. After ten years of hard work and various difficulties, the world's first canine albumin injection was born.

Bolaideli not only focuses on the research and development of innovative pet drugs, but also has been supporting the development of the industry for ten years, integrating the development of the company into the development of the industry, and doing its best for the development of the industry. best efforts. At this press conference, Bolaidli signed a strategic cooperation agreement with the Chinese Veterinary Association and the Beijing Small Animal Diagnosis and Treatment Industry Association, two major industry associations, to jointly promote the development of the industry.

Part.2

In-depth insights into facing challenges

In the conference, Xin Shengpeng, executive vice president and secretary-general of the Chinese Veterinary Association, shared his experience with BOLED over the years Regarding his experience and thoughts on cooperation with Li, he said: Since its establishment in 2013, Bolaidli has proactively fulfilled its industry responsibilities and integrated the development of the company into the development of the industry. Over the years, although Bolaidli itself is very weak and its financial strength was not strong during the hard work period, it has spared no efforts in supporting the work of industry associations at all levels and industry development. The Clinical Veterinary Conference has established public welfare awards such as the "Bolaideli Outstanding Young Veterinary Award", "Bolaideli Outstanding Contribution Award to the Veterinary Industry", and "Bolaideli's Most Beautiful Veterinarian", and has awarded nearly a thousand outstanding Clinical pet physicians, these outstanding representatives of the industry have grown into the backbone of the rapid development of the industry. Boladeli has become a model for enterprises to integrate into the development of the industry, assist the development of the industry, and achieve common development.

——Secretary-General Xin Shengpeng's speech——

As a "life medicine" and "life-saving medicine", albumin is the protein with the highest content and the most important function in plasma. Accounting for 40-60% of total plasma protein. Clinically, albumin has the functions of maintaining plasma colloid osmotic pressure, increasing blood volume, transporting and detoxifying, supplying nutrients, maintaining blood acid-base balance, regulating capillary membrane permeability, and protecting nerves.

During the meeting, senior veterinarian Pan Qingshan shared the application of canine albumin in surgery. He said: Sick dogs suffer heavy blood loss and stress due to trauma, which often leads to the loss of protein in the blood. As a result, blood loss and hypoalbuminemia occur. Canine albumin has the functions of maintaining plasma colloid osmotic pressure, expanding blood volume, transporting drugs and various other small molecule substances. Therefore, during the operation, our supplementation of canine serum albumin is only beneficial to the treatment and recovery of the sick dog, and has no harm.

——Pan Qingshan explains the application of canine albumin in surgery——

——Lv Yanli explains the application of canine albumin in internal medicine——

< p>At the same time, Professor Lu Yanli introduced the application of albumin in internal medicine in detail, focusing on the four causes of hypoalbuminemia (insufficient synthesis, insufficient supply, malabsorption, and protein loss) and analyzed why sick dogs need supplementation. albumin. It is recommended that when you encounter a dog with hypoalbuminemia, you can promptly supplement albumin according to the missing amount. In addition, Professor Lu called on everyone to use compliant veterinary drugs, which is not only responsible for their pets, but also responsible for themselves.

Part.3

Junlu has been striving to break out of the cocoon for ten years

In addition, this meeting also launched the 2024 national "Boshengjian" dog blood test Protein clinical application case competition. A new class of veterinary drugs not only has high research and development costs, but also high promotion costs. In order to improve the clinical use level of canine albumin, it provides opportunities for clinical pet doctors to learn, communicate and improve. Boladeli invested heavily in jointly organizing the Canine Albumin Clinical Application Case Competition with the Chinese Veterinary Medical Association and the Pet Diagnosis and Treatment Branch of the Chinese Veterinary Medical Association. During the conference, Professor Xia Zhaofei introduced the competition system and invited expert leaders Xin Shengpeng, Pan Qingshan, Liu Lang, Niu Guangbin, and Wang Hongwei to jointly unveil the launching ceremony of the competition.

——Launching Ceremony——

After more than ten years of research and development, registration, and GMP workshop construction and certification, Bolaidli finally became the world's first national A new category of veterinary drug, canine albumin injection, was officially approved for sale. At the same time, Bolaidli’s domestically produced high-quality cat triple vaccine will also be approved for marketing. Bolade will use more and better independent innovative products to serve the development of our industry, establish my country's leading position in the field of pet biological products in the world, use the soft technology of research and development and the hard power of production to serve the health of the majority of pets, and provide Bringing joy and happiness to thousands of pet owners.